JON S SAXE Insider Trading $SCLN SCICLONE PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JON S SAXE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JON S SAXE. JON S SAXE is Director in SCICLONE PHARMACEUTICALS INC ($SCLN) and Director in DURECT CORP ($DRRX) and in VistaGen Therapeutics, Inc. ($NA).
JON S SAXE in SCICLONE PHARMACEUTICALS INC
Trading Symbol: SCLNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JON S SAXE: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 16 2017
$SCLN Market Capitalization: $495.21M
$SCLN Previous Close: $9.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JON S SAXE in SCICLONE PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, DRRX, SCLN, VTGN
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | D | 10.90 | 30,000 | 327,000 | 0 | |
Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | D | 9.15 | 30,000 | 274,500 | 0 | |
Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | D | 5.10 | 30,000 | 153,000 | 0 | |
Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | D | 5.13 | 30,000 | 153,900 | 0 | |
Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | D | 6.78 | 30,000 | 203,400 | 0 | |
Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | D | 6.04 | 30,000 | 181,200 | 0 | |
Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | D | 3.01 | 30,000 | 90,300 | 0 | |
Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | D | 2.23 | 30,000 | 66,900 | 0 | |
Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | D | 1.75 | 30,000 | 52,500 | 0 | |
Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Sell | D | 11.18 | 135,000 | 1,509,300 | 0 | 135 K to 0 (-100.00 %) |
Jun 09 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | A | 10.90 | 30,000 | 327,000 | 30,000 | |
Feb 23 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | M | 2.61 | 12,700 | 33,147 | 0 | |
Feb 23 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Buy | M | 2.61 | 12,700 | 33,147 | 135,000 | 122.3 K to 135 K (+10.38 %) |
Feb 17 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | M | 2.61 | 17,300 | 45,153 | 12,700 | |
Feb 17 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Buy | M | 2.61 | 17,300 | 45,153 | 122,300 | 105 K to 122.3 K (+16.48 %) |
Jun 13 2016 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | A | 14.00 | 30,000 | 419,850 | 30,000 | |
Jan 06 2016 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | M | 2.46 | 30,000 | 73,800 | 0 | |
Jan 06 2016 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Buy | M | 2.46 | 30,000 | 73,800 | 105,000 | 75 K to 105 K (+40.00 %) |
Jun 12 2015 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | A | 9.15 | 30,000 | 274,500 | 30,000 | |
Mar 05 2015 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | M | 3.27 | 30,000 | 98,100 | 0 | |
Mar 05 2015 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Buy | M | 3.27 | 30,000 | 98,100 | 75,000 | 45 K to 75 K (+66.67 %) |
Page: 1